BioSynthema Inc.
5Patents
1Active
5Granted
28Portfolio score
Filing activity: Jul 21, 1994 → May 31, 2007 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7202330B2 | RGD (Arg-Gly-Asp) coupled to (neuro)peptides | Chemistry; Metallurgy | 5 | Expired |
| US8293873B2 | Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take | Human Necessities | 4 | Active |
| US6664367B1 | Stable analogs of bioactive peptides containing disulfide linkages | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7122622B2 | Peptide compounds having improved binding affinity to somatostatin receptors | Chemistry; Metallurgy | 2 | Expired |
| US7015306B2 | Labeled neurotensin derivatives | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.